J. Golvano

发表

Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR molecules.

F. Borrás-Cuesta, D. Zeliszewski, I. Dorval, 1994, Human immunology.

Development of Protection against Coronavirus Induced Diseases

J. Castilla, B. Pintado, I. Sola, 1995 .

Development of protection against coronavirus induced diseases. A review.

J. Castilla, B. Pintado, I. Sola, 1995, Advances in experimental medicine and biology.

Overcoming class II-linked non-responsiveness to hepatitis B vaccine.

J. Prieto, C. Berasain, S. Hervás-Stubbs, 1994, Vaccine.

Short Pc)per Overcoming class II-linked non-responsiveness to hepatitis B vaccine

C. Berasain, J. Lasarte, P. Sarobe, 1994 .

Specific and general HLA-DR binding motifs: comparison of algorithms.

E. Huarte, J. Lasarte, J. Riezu-Boj, 2000, Human immunology.

Binding analysis of 95 HIV gp120 peptides to HLA-DR1101 and -DR0401 evidenced many HLA-class II binding regions on gp120 and suggested several promiscuous regions.

S. Le Gac, P Gaudebout, D Zeliszewski, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Binding of ALA-substituted analogs of HA306-320 to DR1101, DR1301, and DR0402 molecules: correlation of DR-peptide interactions with recognition by a single TCR.

F. Borrás-Cuesta, D. Zeliszewski, I. Dorval, 1996, Human immunology.

Sharing of Four DR‐β Sequence Motifs Between HLA‐DRB1*1601 and DRB1*1101 Correlates with Frequent Degenerate T‐Cell Recognition of HA306–320 Peptide Complexed to these Two Molecules

F. Borrás-Cuesta, D. Zeliszewski, I. Dorval, 1996, Scandinavian journal of immunology.

Polarity of immunogens: implications for vaccine design

J. Lasarte, P. Sarobe, F. Borrás-Cuesta, 1990, European journal of immunology.

Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.

L. Gebuhrer, H. Bétuel, F. Borrás-Cuesta, 1993, Journal of immunology.

Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide

J. Lasarte, M. Civeira, P. Sarobe, 1991, European journal of immunology.

Insights on the amino acid side-chain interactions of a synthetic T-cell determinant.

J. Guillaume, J. Lasarte, J. Guillet, 1991, Biologicals : journal of the International Association of Biological Standardization.

Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr.

J. Lasarte, P. Sarobe, F. Borrás-Cuesta, 1994, Journal of acquired immune deficiency syndromes.

Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells.

J. Lasarte, E. Larrea, P. Sarobe, 1993, Research in immunology.

Further insights on the inhibition of HIV type 1 infection in vitro by CD4-modified synthetic peptides containing phenylalanine.

J. Lasarte, M. Civeira, P. Sarobe, 1996, AIDS research and human retroviruses.